Purple biotech to host virtual kol event to discuss positive interim results from phase 2 pancreatic cancer study with cm24 on july 11, 2024

Rehovot, israel, july 10, 2024 (globe newswire) --  purple biotech ltd. ("purple biotech" or "the company") (nasdaq/tase: ppbt), a clinical-stage company developing first-in-class oncology therapies that overcome tumor immune evasion and drug resistance, today announced further details on its virtual key opinion leader (kol) event on thursday, july 11, 2024 at 10:30 am et. to register, click here .
PPBT Ratings Summary
PPBT Quant Ranking